Sitemap
- Ukidney's Nephrology Ask the Expert Discussions
- For Patients
- 3D Printers and Kidney Transplants
- ANCA ASSOCIATED GN
- ANCA MEDIATED CRESCENTIC GN
- Borderline Kidney Function-Drugs or Lupus?
- Can I use topical NSAID cremes or marijuana creams?
- Diets contradict for Kidney failure with type 2 Diabetes
- Kidney function and Antihypertensives - acceptable decrease?
- Kidney Stone
- Very high Plasma Renin Activity, more than 10 times reference range limit.
- Hypertension Questions
- Are there any major changes expected in the CHEP 2012 guidelines?
- CKD and Hypertension
- Combination therapy in Hypertension
- HTN management
- primary hyperaldostronism
- What is the difference between different types of angiotensin receptor blockers?
- Where do you use ACE inhibitors versus ARBs in treating hypertension
- General Nephrology Questions
- A case of crescentic IgA
- Accurate determination of GFR
- ACR Vs AMR
- Acute decline in kidney function (eGFR 25; Cr 179)
- acute renal failure
- ADPKD
- ADPKD and liver disease
- advice needed to avoid dialysis, stage 4 ckd with diabetes
- Am I beginning to feel the symptoms of kidney Diseases?
- An anxious mother for her daughter
- Antibiotics and PD
- ARBs in hyperkalemic patient
- ASA and Plavix use
- Atrophic Left kidney, and Hydronephrosis in the right kidney
- atypical HUS
- Best book on acid- base and electrolytes
- Biologic drugs in patients with renal disease
- C4d staining in AMR
- Can a person with one functioning kidney participate in high impact contact sports?
- Can biologic medications be used in patients with chronic kidney disease?
- catheter related infections
- CNI induced TMA
- Cold or Flu treatment for a Stage 3 PKD patient
- compliments evaluation
- Could this still be Alports?
- Cramps on dialysis
- cryoglobulinemia and proliferative GN
- diltiazem antiproteinuric effect vs adverse effects
- Early post transplant oliguria, hypertension and hyperkalemia?
- Eculizumab and aHUS
- Effect of serum bilirubin on creatinine estimation.
- Effect of severe Hypo albuminemia and Massive proteinuria on falsely lowering eGFR and falsely lowering Serum Creatinine?
- EGFR
- eGFR of 59, does this mean I have CKD? How concerned should I be?
- Erythropoietin and renal cysts
- Excessive urination after rhabdomyolysis
- Ezetimibe for lipid reduction in Chronic Kidney Disease
- febrile rash with renal failure
- Finding a Dietician or Nutritionist
- Fluimucil for Nephritis patient
- For fellowship in nephrology
- frequency of dialysis
- GADOLINUM CONTRAST & HYPOCALCEMIA?
- glomerulonephritis and plasma proteins
- heamangioblastoma
- hearing loss due to renal tubular acidosis
- High urea : creatinine ratio in an overloaded patient
- How immunosuppression during active infection should be managed?
- Hyperphosphatemia , Hyperparathyroidism in dialysis
- Hypothyroidism and CKD
- hypoxia
- I am a 45 yr old female, just diagnosied with stage 3 PKD (GFR 59). I also have hypertension. And cannot find a doctor with answers.
- IgA Nephropathy
- Immunosupression in kidney transplantation
- Inactive ANCA Vasculitis
- Incidental hematuria
- iron dosing in hemodialysis patients
- Is anyone in Toronto treating PKD with Tolvaptan?
- is clinidipine underused medication??
- Is it time
- Is it time to see a Nephrologist?
- isosorbide dinitrate
- kidney
- Kidney failure shortly after transplant; not rejection
- kidney function and bone metabolism
- Light chain deposit disease and dialysis
- Low complemets and liver disease w/o cryoglobulins?
- Membranous glomerulonephritis with gross hematuria
- microalbuminuria and cardiovascular disease
- Microscopic hematuria With pre-existing Ckd. Next step?
- minimal change disease
- Minimal change disease
- MPGN type 1
- muddy brown casts
- Nephrogenic ascites
- Nephrotic syndrome in a patient with recent malignancy
- Oral hypoglycaemic agents in Diabetic Nephropathy
- Painless Papilledmea, loss of visual acuity in CKD stage 4
- peritoneal dialysis
- Permcath insertion length
- Physical Training with Kidney Disease
- PLASMA PROTEINS
- Polymyositis and dermatomyositis in relation with CKD
- post strep-glomerulonephritis but still blood in urine after one year
- Post transplantation HCV management
- posterior urethral valves (PUV)
- Pregnancy in Renal Transplant
- Probable kidney disease?
- proteinuria VS rising creatinine level when using ACEI
- PSGN with Gross Hematuria over a Year later
- Quantification of proteinuria.
- Question about calcium containing phosphate binders
- ratio of urea and creatinine
- renal transplant
- Renal tubelar acidosis and vitamins
- resistant hypertension with polycystic kidney disease
- restarting peritoneal dialysis
- Role of AVF inCKD and ESRD in the progression of Idiopathic Pulmonary HTN
- Role of oral hypoglycemics
- Salt restriction and 24 hour urine sodium
- Should I lift weight light weights and practice Martial Arts with one kidney?
- should we start dialysis?
- Simethicone
- Single Kidney and creatinine
- the next step ?
- Timing the Aspirin and Statin doses
- Toddler with white granules in morning urine... PLEASE ADVICE!!
- Trace protein on dipstick, some from in urine.
- transitioning from hemo to CAPD ascites not from liver failure ,How to treat, and train ?
- Transplant crossmatch
- Treatment of crecentric IgA Nephropathy
- Tunneled IJV catheter insertion in a patient with implantable cardioverter-defibrillator
- Uncontrolled hypertension
- Urinary NGAL and acute renal failure
- Urine output on hemodialysis
- Validity of albumin to Cr ratio in case of raised serum Cr
- Veltassa vs. ZS-9
- Weight lifting with one kidney
- What is microalbuminuria?
- What is the importance of the albumin to creatinine ratio (ACR)?
- What is the nephrology appointment frequency recommended in ckd for stages 1-2-3-4-5 and if I can find it in the litterature
- Will i survive long with bad diabetes kidney disease and no medication?
- Would you biopsy him?
- Complement Dysregulation
- Polycystic Kidney Disease
- Fluid & Electrolyte
- Peritoneal Dialysis
- Hemodialysis
- Metabolic Bone Disease and SHPT
- For Patients
- General Nephrology Presentations
- Hepatitis C: Can we eliminate a cause of CKD
- SGLT2 Inhibition in Diabetic Kidney Disease
- Why hepatitis C matters in patients with chronic kidney disease?
- Fabry disease: What every nephrologist should know
- Journée québécoise de la dialyse 2016
- eGFR and Microalbuminuria
- Dialysis for Poisonings
- Vasculitis and RPGN
- Pulmonary-renal syndrome
- Renal pathology
- Hypertension in pregnancy
- Renal cell carcinoma
- Nephrogenic fibrosing dermopathy
- Kidney stone prevention
- Edema states and diuretics
- Regulation of sodium excretion (Part 1)
- Renal sarcoidosis
- Chinese herb nephropathy
- Renal artery stenting: Indications and end-points
- Electrolyte management in the Elderly
- Surgical management of kidney stones
- Highly active anti-retroviral therapy complications: a Nephrology Perspective
- Lupus Nephritis
- Lithium induced diabetes insipidus
- Pulmonary renal syndromes in the ICU
- Vaptans: Possible treatment for hyponatremia
- Hepatitis C and renal disease
- Wegener's granulomatosis
- Tubulointerstitial nephritis and uveitis (TINU): Case discussion
- Combining medications in the management of hypertension
- Microalbuminuria testing
- Nephrogenic systemic sclerosis: Update 2009
- Hypertension 2009
- Pregnancy in hemodialysis patients
- Acid Base Physiology Update CSN Review Course 2009
- Cardiorenal axis: Preventing and Treating diabetic nephropathy
- Syphilis and renal disease
- Prevention of nephrotoxicity of the chemotherapeutic agent
- Very old persons with chronic kidney disease: is Dialysis harmful?
- Vexing Cases in Lupus Nephritis
- The role of Vitamin D for the prevention of diabetes mellitus and diabetic nephropathy
- Pitfalls in estimating renal failure in the elderly by eGFR
- Dual RAAS Blockade: Rationale and Literature Overview
- Renal Sparing Strategies in Renal Cell Carcinoma
- Managing elderly persons with CKD stages 3-4
- Prenatal determinants for maximum nephron endowment at birth
- Membranous Glomerulonephritis - Dr D Cattran
- Prevention of IgA Nephropathy
- Prevention of Focal Segmental Glomerulosclerosis
- Hepatitis C Glomerulonephritis
- HIV-Associated Kidney Disease
- Paraproteinemias (myeloma - amyloidosis)
- Coping with the Difficult Patient
- Sleep Disorders in Patients with Chronic Kidney Disease
- Supramaximal Dose of Candesartan in Proteinuric Renal Disease
- Proteinuria reduction with ARBs: The DROP Study
- IDNT and IRMA II Trials and Proteinuria Reduction
- Aggressive RAAS blockade should we change practice
- Sickle Cell Anemia and Renal Disease
- Amphotericin B Nephrotoxicity
- Diet and Kidney Stone Prevention
- Continuous Renal Replacement Therapy
- New innovations in Gout: Febuxostat
- Is diabetic nephropathy more than one disease?
- Is there a role for endothelin blockade in diabetic nephropathy?
- Prevention of renal disease in pregnant women with lupus
- Prevention of renal disease in Spina Bifida
- Prevention of progression of IgA nephropathy - the paediatric perspective
- A female with thrombocytopenia and thrombotic Microangiography
- A patient with diabetes, hepatitis C and nephrotic syndrome
- Molecular Mimicry
- A Decade of Progress in Lupus Nephritis
- Membranous nephropathy
- Transition of Pediatric Patients to Adult Nephrology
- Rare pediatric diagnoses now surviving into adulthood
- Transition of Pediatric Patients to Adult Nephrology: Views of an adult Nephrologist
- Diabetic nephropathy - primary prevention and regression
- Prevention of AKI in the elderly
- Overcoming barriers to end-of-life decision making
- Proteinuria and cardiovascular disease
- Renal Disease and Protease Inhibitors in Aging HIV Patients
- Hyperlipidemia Management in CKD
- Proteinuria and cardiorenal outcomes
- Complement dysregulation in thrombotic microangiopathy and the emerging role of Eculizumab
- Volume expanding patients with hyponatremia
- ASN Board Review Course Coverage
- SGLT2 Inhibition: Questions and answers for an emerging therapy
- Journal Club: The use of Atrasentan to reduce proteinuria in diabetic nephropathy
- Journal Club: Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.
- Anticoagulation in Kidney Disease: Options and Considerations
- Spotlight on microangiopathic hemolytic anemias and bone marrow failure syndromes: Concluding remarks
- Spotlight on microangiopathic hemolytic anemias and bone marrow failure syndromes: Pediatric cases
- Approach to a patient with MAHA and thrombocytopenia
- TMA case studies
- Autosomal Dominant Polycystic Kidney Disease (ADPKD) Wall of Experts
- ADPKD Speaking Volumes
- Clinical cases of cancer-associated thrombosis (CAT) in patients with renal dysfunction
- Nephrology in 2016: A year in review
- Hypertension Presentations
- Assessing patients with hypertension
- Treating hypertension
- Focus on Stroke
- RADAR III: BP measurement
- RADAR III: Lifestyle management
- RADAR III: Promoting treatment adherance
- RADAR III: Severe Hypertension
- RADAR III: BP management and diabetic nephropathy
- RADAR III: Microalbuminuria and CV disease
- RADAR III: Hypertension and CKD
- Hypertension management with focus on direct renin inhibitors
- Current Trends and Controversies in the Diagnosis and Treatment of Hypertension
- Olmesartan: Exploring a new antihypertensive
- Olmesartan: Slide library
- Hypertension 2009-Beyond the Cuff-Calgary CME
- Reducing Cardiovascular Disease and Renal Disease by Treating Proteinuria
- Hypertension Management in Type 2 Diabetes
- Can BP control prevent renal damage?
- Hypertension 2010: Principles of Management
- Combination Treatment of Essential Hypertension
- 2014 CHEP Hypertension Treatment Recommendations
- 2015 CHEP hypertension recommendations
- Hemodialysis Presentations
- Urea kinetics
- Dialyzers and dialysis machines
- Hemodialysis adequacy
- Non-infectious complications of HD catheters
- Past, present, future of hemodialysis
- Blood volume monitoring and sodium profiling in HD
- Home and nocturnal hemodialysis
- Acute complications of hemodialysis
- Hemodialysis access emergencies
- Prevention of Intradialytic Hypotension
- Conservative management vs. dialysis in the elderly patient with stage 5 CKD
- Pregnancy in women on dialysis
- Withholding or withdrawing dialysis
- Existential psychotherapy in end of life care
- Atlas of Dialysis Vascular Access
- Rational approach to vascular access in the elderly
- Prevention of RRF loss in dialysis patients
- Physical Examination of Arteriovenous Fistula
- Portable Ultrasound for Hemodialysis Access Assessment and Cannulation
- Journée Québécoise d'hémodialyse 2015
- Peritoneal Dialysis Presentations
- Primer of peritoneal dialysis
- Ultrafiltration failure in PD
- Preservation of renal function
- Noninfectious complications of PD
- Infectious complications of PD
- PD in acute renal failure
- Peritoneal dialysis in the elderly
- Challenging cases in peritoneal dialysis
- Overview and physiology of peritoneal dialysis
- Adequacy of Peritoneal Dialysis
- Peritoneal dialysis: Video Preceptorship
- Update in Peritoneal Dialysis CSN Review Course 2009
- Growth of Peritoneal dialysis: Impact of home assistance
- Controversy of biocompatible solutions in peritoneal dialysis
- Prevention of Peritoneal Dialysis-related infections
- The Importance of Residual Kidney Function For Patients on Dialysis, Dr. Jeffrey Perl
- Peritoneoscopic Insertion of a Peritoneal Dialysis Catheter
- Introduction to PD Catheter Insertion Methods
- Interventional Radiology and Peritoneal Dialysis
- Blind bedside insertion of PD Catheters
- The Embedded Peritoneal Dialysis Catheter
- Peritoneal Dialysis Adequacy
- Non-infectious complications of Peritoneal Dialysis
- The Physiology of Peritoneal Dialysis
- The Importance of Residual Kidney Function For Patients on Dialysis
- Diagnosis of Encapsulating Sclerosing Peritonitis
- Encapsulating Sclerosing Peritonitis: Radiological perspective
- Prevention of sudden death in the dialysis patient
- Prevention of peritonitis in patients on PD
- PD Access Triage and the Role of a PD Access Coordinator
- Post-Implantation Management of PD Catheters
- Buried PD Catheters
- PD Catheter Insertion Techniques
- PD Catheter Insertion: The Surgeon's Perspective
- Approach to Malfunctioning PD Catheters
- PD Catheter Insertion: The Radiologist's Perspective
- PD Catheter Insertion: The Nephrologist's Perspective
- Access Complications: PD vs. HD
- Indications for PD Catheter Removal
- PD Catheter Types and Clinical Outcomes
- Chronic Kidney Disease
- Biology of uremia: Vascular disease
- Detection, monitoring and referral of chronic kidney disease
- Pulmonary hypertension in end-stage renal disease
- Prevention of Chronic Kidney Disease in patients with disorders of the complement system
- Sudden Death in Chronic Kidney Disease
- A Trial of Care for CKD: Can-Prevent
- EMiNEM: Education in Mineral Metabolism
- Essential concepts in chronic renal failure
- Renal Anatomy and Physiology: a foundation for learning about chronic renal failure
- Cardiovascular complications of chronic kidney disease
- Renal anemia
- Chronic Kidney Disease: Overview
- Bone and Mineral Metabolism and Disease in CKD
- The Impact of Phosphate Food Additives in Chronic Kidney Disease
- The relevance of the attachment system for adapting to chronic illness
- Haemoglobin: A moving target in CKD Patients
- The TREAT study: prevention of Anaemia in Diabetic Patients with CKD - Dr. Patrick Parfrey
- Interventions in ESRD/CKD patients with cardiac Disease - Dr. Patrick Parfrey
- Is there role of statins in cardiovascular protection in CKD patients stages 3-4 - Dr. Marcello Tonelli
- Sexual function and quality of life in patients with CKD
- Screening and treatment of sexual dysfunction in patients with CKD
- Prevention of long-term sequelae of pre-eclampsia
- Detecting CKD in the elderly: When a decreased eGFR is CKD
- Is renoprotection worthwhile in the elderly patient with hypertension and/or CKD
- Prevention of cardiovascular morbidity in adolescents with childhood onset CKD - Dr. Rulan Parekh
- Psychological concepts in sexuality in patients with renal disease
- Beta Blockers in Chronic Kidney Disease
- Kidney Health - Spreading the Word
- The role of hyperuricemia in CKD
- Chronic Kidney Disease and Osteoporosis: How to Diagnose and Treat
- Sex hormones and progression of CKD
- Chronic Kidney Disease Web Series
- Module 5: Mineral and Bone Disorder (CKD-MBD)
- Module 1: A Foundation for Learning about Chronic Renal Failure
- Module 2: Cardiovascular Complications of Chronic Kidney Disease
- Module 3: Anemia in CKD
- Module 4: Chronic Kidney Disease
- Fractures across the spectrum of CKD
- Anemia Wall of Experts - Iron Deficiency in CKD
- Renal Transplantation Presentations
- Using organs from high risk donors
- Renal transplant surgery
- Fungal infections in transplantation
- Hypertension after renal transplant
- Transplant emergencies
- Viral infections in renal transplantation
- Essentials of live kidney donation
- Overview of renal transplantation
- Kidney Pancreas Transplantation
- Immunosuppressive Medications
- Tissue typing and cross-matching in kidney transplantation
- Hepatitis B in renal transplant recipients
- BK Polyoma virus infection in renal transplantation
- Commercial transplantation
- Essential clinical issues in renal transplantation
- Prevention of nephrotoxicity of immunosuppressive agents in kidney transplantation
- Living donor assessment and long-term complications
- Statins and RAS blockade in prevention of kidney disease in kidney transplantation
- Transition of Pediatric Renal Transplant Patients to Adult Nephrology
- Prevention of late immunologically mediated chronic kidney allograft injury
- Prevention of non immunologically mediated chronic kidney allograft injury
- Update in Pancreas Transplantation
- Bone and Mineral Metabolism Presentations
- Vitamin D in chronic kidney disease
- Overview of bone and minreal metabolism
- Hyperparathyroidism - Focus on calcium
- Vascular calcification in CKD
- Biology of uremia: Calcium, Phosphate and Vitamin D
- Fosrenol: An overview of a new phosphorus binder
- Introduction to the KDIGO Guidelines
- Vascular calcification symposium 2009
- Renal Osteodystrophy: What's New
- The Importance of Vitamin D
- Latest Developments in Bone Mineral Metabolism
- Learning From Images in Nephrology
- Dysfunctional Dialysis Catheter
- Vascular Extension from an Infiltrating Renal Tumor
- Renal Volume in Polycystic Kidney Disease
- Seroma Related to Prosthetic Arteriovenous Graft
- Staghorn Calculi
- Hemodialysis Catheter Misadventure: Can We Prevent This Fundamental Mistake?
- Aneurysmal Dilatation of Dialysis Arteriovenous Access
- Hand Pain with Dialysis Access: Is it Always Steal Syndrome?
- Transplant Renal Artery Stenosis
- Perinephric Lymphoma
- Arteriovenous fistula stenting: Size matters
- Frosty Man
- Yin-yang sign in arteriovenous fistula pseudoaneurysm
- Fundamental Mistake During Tunneled Hemodialysis Catheter (TDC) Removal
- Encapsulating Peritoneal Sclerosis
- Toxicology
- General Nephrology Videos
- Renal Transplantation Videos
- Peritoneal Dialysis Videos
- Renal Pathology Videos
- Histopathology Kidney - Systemic lupus erythematosus
- Histopathology Kidney - Acute tubular necrosis from ethylene
- Histopathology Kidney - Rapidly progressive glomerulonephritis
- Histopathology Kidney - Interstitial nephritis
- Histopathology Kidney - Arteriolosclerosis (hypertension)
- Histopathology Kidney - Adult polycystic disease
- Histopathology Kidney - Acute and chronic pyelonephritis
- Histopathology Kidney - Wilms tumor
- Histopathology Kidney - Transitional cell carcinoma
- Histopathology Kidney - Renal cell carcinoma
- Histopathology Kidney - Septic infarct
- Histopathology Kidney - Diabetic glomerulosclerosis
- Histopathology Kidney - Acute transplant rejection
- Histopathology Kidney - Acute tubular necrosis
- Histopathology Kidney - Membranous glomerulonephritis
- Hemodialysis Videos
- All Nephrology Manuals
- KDIGO Guidelines
- CSN Guidelines
- Calculators and Tools
- Nephrology News
- General nephrology
- ACE and ARB in combination: Still a viable option?
- Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
- Are calcium-based phosphate binders obsolete?
- ASH: Calcium Channel Blocker Benefits in ACCOMPLISH Not Explained by Ambulatory BP
- Bardoxolone in Chronic Kidney Disease: A major breakthrough?
- Bardoxolone study terminated over excess mortality
- Calcium-based phosphate binders likely harmful in CKD
- Cinacelcet and cardiovascular outcomes: neutral study underscores a fundamental problem in nephrology research
- Dilemma for Dialysis Patients, Skinny is Dangerous
- Dream RCT: A placebo-controlled trial of hyperphosphatemia management
- eGFR and microalbuminuria: a powerful duo
- Empagliflozin and renal outcomes: further insights in to the renal protection of SGLT2 inhibitors
- Fascinating new therapy for PCKD on the horizon
- Generic drugs: a dangerous public misunderstanding?
- High cut-off hemodialysis for the treatment of multiple myeloma
- INSPRA approved as adjunct to standard therapy to reduce risk of death
- Jinarc (Tolvaptan) approved in Canada for the management of autosomal dominant polycystic kidney disease (ADPKD)
- More evidence for mycophenolate mofetil in lupus nephritis
- More positive news for Tolvaptan (Jinarc) in ADPKD: Reprise Study topline results
- MR elastography: Revolutionizing the assessment of renal fibrosis
- Renal outcomes with Empagliflozin: a game-changer
- SAVOR Trial Negative: No CVD advantage for Saxagliptin
- SGLT2 inhibitors and nephroprotection: a perspective on the renal outcome data
- Sodium bicarbonate replacement delays progression of chronic kidney disease
- Statins in end-stage renal failure: failure revisted
- Tolvaptan in Polycystic Kidney Disease (ADPKD): the most exciting nephrology development in years
- Treating microalbuminuria to reduce cardiovascular disease: an increasingly dangerous strategy
- Kidney transplantation
- Hypertension
- Angiotensin Receptor Blockers and Cancer
- Benlysta: Promising new Lupus drug on the horizon
- Blood pressure targets called in to question? Yes and No
- Calcium channel blockers and breast cancer: an important risk factor discovered?
- Calcium channel blockers and breast cancer: Update
- Chloroquine in Lupus: Prevents flares and saves lives
- Class Review of Phosphate Binders
- Empagliflozin and renal outcomes: Further insights to a proven hypothesis
- Ezetimibe and Simvastatin in Chronic Kidney Disease: Good News
- FDA approves 4 H1N1 vaccines
- Growing new kidneys? An idea whose time may have come
- Hyperphosphatemia management - It is time for a randomized trial
- Important genetic link found for FSGS in African Americans
- Is rosuvastatin (Crestor) nephrotoxic?
- KDIGO Bone and Mineral Guidelines now available
- No benefit of Aliskiren added on to ACE or ARB: a disappointing development
- Olmesartan delays the onset of microalbuminuria, but more deaths seen
- Racing to apply the SPRINT study to your practice? Not so fast
- Removing a failed kidney allograft improves survival?
- Renal denervation safe, but fails to meet primary end-points in Symplicity 3
- Renal end-points in the ACCOMPLISH Study: Is it all hype?
- Sirolimus and Everolimus in Polycystic Kidney Disease
- The ACCORD Blood Pressure Study: The J-point realized?
- Thiazide diuretics are not created equal, especially with the new ARB azilsartan
- Transplant Drug Two-Year Study Outcomes Show Superior Kidney Function
- TREAT Trial with Aranesp in patients with diabetes and chronic kidney disease
- Vitamins are harmful in patients with chronic kidney disease
- Nephrology Education
- General nephrology
